Moran Mieron
Technik-/Wissenschafts-/F&E-Leiter bei UROGEN PHARMA LTD.
Aktive Positionen von Moran Mieron
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
UROGEN PHARMA LTD. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Pluristem Ltd.
Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The private company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Moran Mieron
Ehemalige bekannte Positionen von Moran Mieron
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
QUOIN PHARMACEUTICALS, LTD. | Technik-/Wissenschafts-/F&E-Leiter | 19.02.2014 | 15.05.2016 |
Ausbildung von Moran Mieron
Technion-Israel Institute of Technology | Doctorate Degree |
Statistik
International
Israel | 4 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
UROGEN PHARMA LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Cellect Biotechnology Ltd.
Cellect Biotechnology Ltd. Medical SpecialtiesHealth Technology Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. | Health Technology |
Pluristem Ltd.
Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The private company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Commercial Services |
- Börse
- Insiders
- Moran Mieron
- Erfahrung